| Structural and functional characterization of nanobodies that neutralize Omicron variants of SARS-CoV-2 K Cornish, J Huo, L Jones, P Sharma, JW Thrush, S Abdelkarim, A Kipar, ... Open Biology 14, 230252, 2024 | | 2024 |
| Mosaic RBD Nanoparticles Elicit Protective Immunity Against Multiple Human Coronaviruses in Animal Models Y Zhang, J Sun, J Zheng, S Li, H Rao, J Dai, Z Zhang, Y Wang, D Liu, ... Advanced science 11 (9), 2303366, 2024 | 2 | 2024 |
| Antibody agonists trigger immune receptor signaling through local exclusion of receptor-type protein tyrosine phosphatases AH Lippert, C Paluch, M Gaglioni, MT Vuong, J McColl, E Jenkins, ... Immunity 57 (2), 256-270. e10, 2024 | 3 | 2024 |
| Single domain antibodies that target sars-cov-2 HUO Jiandong, R Owens, J Naismith US Patent App. 18/044,897, 2023 | | 2023 |
| Single domain antibodies binding to sars-cov-2 spike protein HUO Jiandong, R Owens, J Naismith, D Stuart US Patent App. 17/923,142, 2023 | | 2023 |
| Generation of SARS-CoV-2 escape mutations by monoclonal antibody therapy M Ragonnet-Cronin, R Nutalai, J Huo, A Dijokaite-Guraliuc, R Das, ... Nature Communications 14 (1), 3334, 2023 | 23 | 2023 |
| Rapid escape of new SARS-CoV-2 Omicron variants from BA. 2-directed antibody responses A Dijokaite-Guraliuc, R Das, D Zhou, HM Ginn, C Liu, HME Duyvesteyn, ... Cell reports 42 (4), 2023 | 20 | 2023 |
| Antigenic characterization of SARS-CoV-2 Omicron subvariants XBB. 1.5, BQ. 1, BQ. 1.1, BF. 7 and BA. 2.75. 2 A Zhu, P Wei, M Man, X Liu, T Ji, J Chen, C Chen, J Huo, Y Wang, J Zhao Signal Transduction and Targeted Therapy 8 (1), 125, 2023 | 28 | 2023 |
| SARS-CoV-2 triggers pericyte-mediated cerebral capillary constriction C Hirunpattarasilp, G James, J Kwanthongdee, F Freitas, J Huo, H Sethi, ... Brain 146 (2), 727-738, 2023 | 31 | 2023 |
| A delicate balance between antibody evasion and ACE2 affinity for Omicron BA. 2.75 J Huo, A Dijokaite-Guraliuc, C Liu, D Zhou, HM Ginn, R Das, P Supasa, ... Cell reports 42 (1), 2023 | 40 | 2023 |
| Antigenic characterization of SARS-CoV-2 Omicron subvariant BA. 4.6 A Dijokaite-Guraliuc, R Das, R Nutalai, D Zhou, AJ Mentzer, C Liu, ... Cell Discovery 8 (1), 127, 2022 | 5 | 2022 |
| Humoral responses against SARS-CoV-2 Omicron BA. 2.11, BA. 2.12. 1 and BA. 2.13 from vaccine and BA. 1 serum J Huo, A Dijokaite-Guraliuc, R Nutalai, R Das, D Zhou, AJ Mentzer, EE Fry, ... Cell Discovery 8 (1), 119, 2022 | 4 | 2022 |
| GPC3-Unc5 receptor complex structure and role in cell migration O Akkermans, C Delloye-Bourgeois, C Peregrina, M Carrasquero-Ordaz, ... Cell 185 (21), 3931-3949. e26, 2022 | 18 | 2022 |
| Differences in CD80 and CD86 transendocytosis reveal CD86 as a key target for CTLA-4 immune regulation A Kennedy, E Waters, B Rowshanravan, C Hinze, C Williams, D Janman, ... Nature immunology 23 (9), 1365-1378, 2022 | 94 | 2022 |
| Correlation between the binding affinity and the conformational entropy of nanobody SARS-CoV-2 spike protein complexes H Mikolajek, M Weckener, ZF Brotzakis, J Huo, EV Dalietou, A Le Bas, ... Proceedings of the National Academy of Sciences 119 (31), e2205412119, 2022 | 17 | 2022 |
| GPC3-Unc5D complex structure and role in cell migration O Akkermans, C Delloye-Bourgeois, C Peregrina, M Carrasquero-Ordaz, ... bioRxiv, 2022.07. 21.500812, 2022 | | 2022 |
| Genome-first detection of emerging resistance to novel therapeutic agents for SARS-CoV-2 M Ragonnet-Cronin, R Nutalai, J Huo, A Dijokaite-Guraliuc, R Das, ... bioRxiv, 2022.07. 14.500063, 2022 | 3 | 2022 |
| Antibody escape of SARS-CoV-2 Omicron BA. 4 and BA. 5 from vaccine and BA. 1 serum A Tuekprakhon, R Nutalai, A Dijokaite-Guraliuc, D Zhou, HM Ginn, ... Cell 185 (14), 2422-2433. e13, 2022 | 593 | 2022 |
| Pathogen-sugar interactions revealed by universal saturation transfer analysis CJ Buchanan, B Gaunt, PJ Harrison, Y Yang, J Liu, A Khan, AM Giltrap, ... Science 377 (6604), eabm3125, 2022 | 27 | 2022 |
| Potent cross-reactive antibodies following Omicron breakthrough in vaccinees R Nutalai, D Zhou, A Tuekprakhon, HM Ginn, P Supasa, C Liu, J Huo, ... Cell 185 (12), 2116-2131. e18, 2022 | 125 | 2022 |
